Xtx Topco LTD Pacira Bio Sciences, Inc. Transaction History

Xtx Topco LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$25.5 - $31.51 $2,244 - $2,772	88 Added 0.96%	9,222 $263,000
Q1 2024 May 13, 2024	BUY	$27.7 - $35.48 $253,011 - $324,074	9,134 New	9,134 $266,000
Q3 2023 Nov 13, 2023	BUY	$30.68 - $40.09 $170,488 - $222,780	5,557 Added 69.19%	13,588 $416,000
Q2 2023 Aug 14, 2023	BUY	$36.12 - $47.5 $290,079 - $381,472	8,031 New	8,031 $321,000
Q4 2022 Feb 14, 2023	BUY	$38.19 - $57.45 $669,165 - $1.01 Million	17,522 New	17,522 $676,000
Q2 2021 Aug 12, 2021	SELL	$59.18 - $69.99 $170,793 - $201,991	-2,886 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$59.31 - $78.82 $171,168 - $227,474	2,886 New	2,886 $202,000

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.